NASDAQ NMS - GLOBAL MARKET · OVID
+1.13% · +$0.0300 · Vol 919.7K
Market closed · last close 4:00 PM ET · price as of 19:12:57 ET
Ovid Therapeutics Inc

Ovid Therapeutics Inc

Biotechnology
$2.68
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
OVID
Ovid Therapeutics Inc
Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

63/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is OVID moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading OVID catalysts
About Ovid Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2017
Employees
23
Country
US

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.69
Day high
$2.69
Day low
$2.60
Previous close
$2.65
52W high
$2.96
-9.46% from high
52W low
$0.5149
89% of range
Market cap
$494.6M
EPS
$-0.8000
Beta
0.64
Shares out
186.6M
Volume
919.7K
0.39× rel vol
Avg volume
2.4M
VWAP
$2.63
Price history computed in-house
1W
+20.72%
1M
+3.08%
3M
-4.29%
1Y
+420.49%
YTD
+64.42%
SMA 50 $2.46 · above
SMA 200 $2.06 · above
52W position 89%

OVID overview

Veridion Score
63
4 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around OVID.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading OVID Form 4 filings
Public disclosures

Congress activity in OVID

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for OVID in the cached public ledger.

Federal contracts

OVID contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OVID in this window.
Lobbying spend

OVID lobbying filings, year to date.

Registered lobbying filings matched to Ovid Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OVID in this window.
Loading news for OVID
Analyst ratings
Sovereign unlock shows live analyst consensus for OVID.
Options
Sovereign unlock shows live options positioning for OVID.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.